Background: Epidural analgesia (EA) has been suggested to be a key element within the enhanced recovery after surgery guidelines for elective colonic surgery (ERAS). However, divergent descriptions exist concerning the optimal duration of epidural analgesia in ERAS. Our study objective was to investigate associations between epidural analgesia duration, length of stay and complication rate, focusing on the value of a third or fourth day of use. Methods: In retrospective analysis, 243 patients who underwent elective colonic surgery according to ERAS and received EA as postoperative analgesic regimen between 2009 and 2012 were studied. Data were pooled according to the duration of EA, groups 1 to 4: ≤ 24 h , >24 to ≤48 h, >48 to ≤72 h and >72 h, respectively. Length of stay (LOS) in days, complication rate, patient controlled intravenous analgesia (PCIA) opioid consumption, reason for termination of EA and other characteristics were documented. Results: Overall median LOS was 7.9 days, interquartile range (IQR) 7. LOS differed among the 4 groups (p<0.001) and was significantly higher in group 4 (19.3, IQR 21) compared to all other groups (1 to 3 respectively: 9.0, IQR 8, p=0.036; 6.8, IQR 6, p<0.001; 7.0, IQR 6, p<0.001). Median LOS in group 2 was also significantly lower compared to group 1 (p=0.033). No differences were found comparing group 3 to groups 1 and 2 (p=0.129; p=0.224). Overall median complication rate was 0, IQR 1, and differed among the 4 groups (p=0.001). It was significantly higher in group 4 (1, IQR 2) compared to all other groups (1 to 3 respectively: 1, IQR 2, p=0.040; 0, IQR 1, p=0.005; 1, IQR 2, p<0.001). Opioid consumption through PCIA after termination of EA differed significantly between group 1 and group 2 while its duration did not (87.8±35.2 mg vs. 62.4±39.3 mg, p=0.025; 54.8±19.2 hrs vs. 45.1±21.2 hrs, p=0.094). Conclusions: Maintaining epidural analgesia (EA) beyond 48 hours postoperatively is not associated with prolonged LOS or an increased complication rate. The third 24 hour period decreases change-over to PCIA. However, prolongation of EA beyond 72 hours is associated with increased LOS and complication rate within the conglomerate of factors in the ERAS clinical pathway in this exploratory study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.